US Stock MarketDetailed Quotes

GBIO Generation Bio

Watchlist
  • 1.070
  • -0.040-3.60%
Close Dec 27 16:00 ET
  • 1.080
  • +0.010+0.93%
Post 19:24 ET
71.47MMarket Cap-0.49P/E (TTM)

About Generation Bio Company

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

Company Profile

SymbolGBIO
Company NameGeneration Bio
Listing DateJun 12, 2020
Issue Price19.00
Founded2016
CEODr. Geoffrey McDonough, M.D.
MarketNASDAQ
Employees174
Fiscal Year Ends12-31
Address301 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-655-7500

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Geoffrey McDonough, M.D.
  • President, Chief Executive Officer and Director
  • 2.32M
  • Dr. Phillip Samayoa, PhD
  • Chief Strategy Officer
  • --
  • Matthew Stanton, PhD
  • Chief Scientific Officer
  • 1.15M
  • Dr. Matthew Norkunas, M.B.A.,M.D.
  • Chief Financial Officer and Principal Accounting Officer
  • 1.14M
  • Yalonda Howze, J.D.
  • Chief Legal Officer and Secretary
  • 1.21M
  • Antionette Paone, M.B.A.,M.S.
  • Chief Operating Officer
  • --
  • Jason P. Rhodes
  • Chairman of the Board
  • 181.21K
  • Ronald H.W. Cooper
  • Independent Director
  • 144.21K
  • Charles A. Rowland, Jr,M.B.A.
  • Independent Director
  • 151.21K
  • Gustav A. Christensen
  • Independent Director
  • 143.71K
  • Dr. Jeffrey M. Jonas,M.D.
  • Independent Director
  • 140.21K
  • Dr. Donald W. Nicholson, PhD
  • Independent Director
  • 143.71K
  • Dr. Catherine Stehman-Breen, M.D.
  • Independent Director
  • 143.71K
  • Dannielle Appelhans
  • Independent Director
  • 140.21K
  • Anthony G. Quinn, Ch.B.,M.B.,PhD
  • Independent Director
  • 143.71K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.